5258.0000 13.50 (0.26%)
NSE Apr 02, 2026 15:31 PM
Volume: 70,183
 

5258.00
0.26%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 589 to 613 in Dec 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended